Merck
MRK
$128.36
Share price
-0.72%
Change (1 day)
10.30%
Change (1 year)
Categories
Merck (MRK) - P/B ratio
P/B ratio as of May 2024 : 8.70
According to Merck's latest financial reports the company has a price-to-book ratio of 8.70.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Merck - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 7.34 | 20.19% |
| 2022-12-31 | 6.11 | 20.7% |
| 2021-12-31 | 5.06 | -37.89% |
| 2020-12-31 | 8.15 | -8.27% |
| 2019-12-31 | 8.88 | 20.52% |
| 2018-12-31 | 7.37 | 66.17% |
| 2017-12-31 | 4.43 | 10.13% |
| 2016-12-31 | 4.03 | 22.72% |
| 2015-12-31 | 3.28 | -0.67% |
| 2014-12-31 | 3.30 | 17.97% |
| 2013-12-31 | 2.80 | 25.34% |
| 2012-12-31 | 2.23 | 10.71% |
| 2011-12-31 | 2.02 | 3.2% |
| 2010-12-31 | 1.96 | 5.86% |
| 2009-12-31 | 1.85 | -39.16% |
| 2008-12-31 | 3.04 | -50.47% |
| 2007-12-31 | 6.13 | 29.51% |
| 2006-12-31 | 4.73 | 39.03% |
| 2005-12-31 | 3.40 | -5.53% |
| 2004-12-31 | 3.60 | -31.56% |
| 2003-12-31 | 5.27 | -4.43% |
| 2002-12-31 | 5.51 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.20 | -40.26% | 🇺🇸 USA |
 Novartis NVS | 5.25 | -39.68% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.80 | -79.26% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.69 | -46.05% | 🇺🇸 USA |
 Eli Lilly LLY | 55.8 | 541.69% | 🇺🇸 USA |
 Amgen AMGN | 26.6 | 205.14% | 🇺🇸 USA |
 Sanofi SNY | 1.55 | -82.18% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 5.52 | -36.56% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.53 | -36.48% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 2.35 | -72.96% | 🇮🇱 Israel |